The ISPOR value flower has provided the field with a list of ‘what’ novel value elements should be incorporated into cost-effectiveness analysis (CEA), among them the value of health equity. Health equity, while important to consider, does not have an established system of measurement and weighting on economic evaluation. Recent measurement and methodological advancements that consider the importance of health equity on decision-making can play into approaches for generalized cost-effectiveness analysis (GCEA).

Padula will provide an overview GCEA and the relative importance of adjusting economic models for health equity. Lakdawalla will introduce the generalized risk-adjusted cost-effectiveness (GRACE) framework as a way of overcoming discriminatory decision-making by adjusting for baseline disability and concerns about health equity. Basu will introduce a new measurement system to health utility, Healthy Years in Total (HYT) as an alternative to QALYs that addressed health equity concerns. Vasco Pontinha will introduce a novel method to encapsulate health equity based on budgetary constraints for mainstream health technologies. At the end of the workshop, the discussants will poll the audience about which method(s) may be able to gain traction to make U.S. health technology assessment processes more equitable.